Imaging suggests HCC, yet cirrhosis is uncertain—see why biopsy matters and how AFP, spread, and liver function shape treatment. For oncology clinicians, the Liver Imaging-Reporting and Data System ...

Vice President Kashim Shettima has taken a swipe at the African Democratic Congress after irregular names and details surfaced on the party’s online membership registration portal. The ADC had ...

A chieftain of the African Democratic Congress (ADC), Aisha Yesufu, has defended the party’s online membership portal following criticisms over alleged glitches. She stated this on Thursday when she ...

On February 25, 2026, IDEAYA Biosciences, Inc. (NASDAQ:IDYA) announced that the first patient has been enrolled in its Phase 1 dose escalation and expansion trial evaluating IDE034, an investigational ...

Vice President Kashim Shettima has mocked the African Democratic Congress (ADC) over its ongoing online membership registration, claiming the platform had been flooded with fake identities. Shettima ...

According to the vice president, the development showed what he described as the opposition’s reliance on misinformation and propaganda. Nigeria’s Vice President, Kashim Shettima, has mocked the ...

The spokesperson of the African Democratic Congress, Bolaji Abdullahi, on Tuesday said the party had corrected observed anomalies on its digital membership registration platform following widespread ...

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG ...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with ...

Add Yahoo as a preferred source to see more of our stories on Google. Alejandra Saitas visits her cardiologist Jeffrey Apple, who performed a stroke prevention procedure on Saitas after she had a ...

SHANGHAI, Jan. 22, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed in a ...